These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8635881)

  • 1. Interconnection between organellar functions, development and drug resistance in the protozoan parasite, Toxoplasma gondii.
    Tomavo S; Boothroyd JC
    Int J Parasitol; 1995 Nov; 25(11):1293-9. PubMed ID: 8635881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of compounds that suppress Toxoplasma gondii tachyzoites and bradyzoites.
    Murata Y; Sugi T; Weiss LM; Kato K
    PLoS One; 2017; 12(6):e0178203. PubMed ID: 28609444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an in vitro system to study the developmental stages of Toxoplasma gondii using a genetically modified strain expressing markers for tachyzoites and bradyzoites.
    Portes JA; De Souza W
    Parasitol Res; 2019 Dec; 118(12):3479-3489. PubMed ID: 31728720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of tachyzoite to bradyzoite differentiation mutants in Toxoplasma gondii reveals a hierarchy of gene induction.
    Singh U; Brewer JL; Boothroyd JC
    Mol Microbiol; 2002 May; 44(3):721-33. PubMed ID: 11994153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxoplasma gondii: kinetics of bradyzoite-tachyzoite interconversion in vitro.
    Soete M; Fortier B; Camus D; Dubremetz JF
    Exp Parasitol; 1993 May; 76(3):259-64. PubMed ID: 7684705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development and biology of bradyzoites of Toxoplasma gondii.
    Weiss LM; Kim K
    Front Biosci; 2000 Apr; 5():D391-405. PubMed ID: 10762601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of cytochrome b from Toxoplasma gondii and Q(o) domain mutations as a mechanism of atovaquone-resistance.
    McFadden DC; Tomavo S; Berry EA; Boothroyd JC
    Mol Biochem Parasitol; 2000 Apr; 108(1):1-12. PubMed ID: 10802314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary culture of skeletal muscle cells as a model for studies of Toxoplasma gondii cystogenesis.
    Guimarães EV; de Carvalho L; Barbosa HS
    J Parasitol; 2008 Feb; 94(1):72-83. PubMed ID: 18372624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cell culture system for study of the development of Toxoplasma gondii bradyzoites.
    Weiss LM; Laplace D; Takvorian PM; Tanowitz HB; Cali A; Wittner M
    J Eukaryot Microbiol; 1995; 42(2):150-7. PubMed ID: 7757057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage-specific expression of surface antigens by Toxoplasma gondii as a mechanism to facilitate parasite persistence.
    Kim SK; Boothroyd JC
    J Immunol; 2005 Jun; 174(12):8038-48. PubMed ID: 15944311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sporozoites of Toxoplasma gondii lack dense-granule protein GRA3 and form a unique parasitophorous vacuole.
    Speer CA; Tilley M; Temple ME; Blixt JA; Dubey JP; White MW
    Mol Biochem Parasitol; 1995 Dec; 75(1):75-86. PubMed ID: 8720177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the Activity of Decoquinate and Its Quinoline-
    Ramseier J; Imhof D; Anghel N; Hänggeli K; Beteck RM; Balmer V; Ortega-Mora LM; Sanchez-Sanchez R; Ferre I; Haynes RK; Hemphill A
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further evidence that naphthoquinone inhibits Toxoplasma gondii growth in vitro.
    da Silva LL; Portes Jde A; de Araújo MH; Silva JL; Rennó MN; Netto CD; da Silva AJ; Costa PR; De Souza W; Seabra SH; DaMatta RA
    Parasitol Int; 2015 Dec; 64(6):622-31. PubMed ID: 26335616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of PERK eIF2α Kinase Inhibitor against Toxoplasma gondii.
    Augusto L; Martynowicz J; Staschke KA; Wek RC; Sullivan WJ
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181373
    [No Abstract]   [Full Text] [Related]  

  • 15.
    Sugi T; Tu V; Ma Y; Tomita T; Weiss LM
    mBio; 2017 Aug; 8(4):. PubMed ID: 28851850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of Autophagy interferes the tachyzoite to bradyzoite transformation of Toxoplasma gondii.
    Li X; Chen D; Hua Q; Wan Y; Zheng L; Liu Y; Lin J; Pan C; Hu X; Tan F
    Parasitology; 2016 Apr; 143(5):639-45. PubMed ID: 26928609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted disruption of the bradyzoite-specific gene BAG1 does not prevent tissue cyst formation in Toxoplasma gondii.
    Bohne W; Hunter CA; White MW; Ferguson DJ; Gross U; Roos DS
    Mol Biochem Parasitol; 1998 May; 92(2):291-301. PubMed ID: 9657333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of N-phenyl-1,10-phenanthroline-2-amines against tachyzoites and bradyzoites of Toxoplasma gondii.
    Martins-Duarte ES; Portes JA; da Silva RB; Pires HS; Garden SJ; de Souza W
    Bioorg Med Chem; 2021 Nov; 50():116467. PubMed ID: 34666274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of compound libraries for inhibitors of Toxoplasma growth and invasion.
    Han Y; Adeyemi OS; Kabir MHB; Kato K
    Parasitol Res; 2020 May; 119(5):1675-1681. PubMed ID: 32236711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sterculic Acid and Its Analogues Are Potent Inhibitors of Toxoplasma gondii.
    Hao P; Alaraj IQ; Dulayymi JR; Baird MS; Liu J; Liu Q
    Korean J Parasitol; 2016 Apr; 54(2):139-45. PubMed ID: 27180571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.